Theravance Biopharma shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.7M | 115k | 14.60 |
| 2025-06-30 | $1.2M | 111k | 11.03 |
| 2025-03-31 | $1.0M | 118k | 8.93 |
| 2024-12-31 | $1.1M | 116k | 9.41 |
| 2024-09-30 | $976k | 121k | 8.06 |
| 2024-06-30 | $1.3M | 151k | 8.48 |
| 2024-03-31 | $1.5M | 162k | 8.97 |
| 2023-12-31 | $2.2M | 196k | 11.24 |
| 2023-09-30 | $1.8M | 203k | 8.63 |
| 2023-06-30 | $2.2M | 216k | 10.35 |
| 2023-03-31 | $2.3M | 210k | 10.85 |
| 2022-12-31 | $2.4M | 212k | 11.22 |
| 2022-09-30 | $2.1M | 206k | 10.14 |
| 2022-06-30 | $1.6M | 182k | 9.07 |
| 2022-03-31 | $1.8M | 190k | 9.56 |
| 2021-12-31 | $2.0M | 188k | 10.53 |
| 2021-09-30 | $1.3M | 176k | 7.41 |
| 2021-06-30 | $2.5M | 175k | 14.53 |
| 2021-03-31 | $4.1M | 202k | 20.41 |
| 2020-12-31 | $3.7M | 206k | 17.78 |
| 2020-09-30 | $3.1M | 211k | 14.78 |
| 2020-06-30 | $4.5M | 215k | 20.96 |
| 2020-03-31 | $4.9M | 211k | 23.11 |
| 2019-12-31 | $5.3M | 203k | 25.90 |
| 2019-09-30 | $3.8M | 197k | 19.48 |
| 2019-06-30 | $3.4M | 208k | 16.34 |
| 2019-03-31 | $4.7M | 209k | 22.68 |
| 2018-12-31 | $5.3M | 208k | 25.59 |
| 2018-09-30 | $6.7M | 206k | 32.67 |
| 2018-06-30 | $4.7M | 206k | 22.68 |
| 2018-03-31 | $5.1M | 210k | 24.25 |
| 2017-12-31 | $5.9M | 211k | 27.88 |
| 2017-06-30 | $8.3M | 208k | 39.83 |
| 2017-03-31 | $7.6M | 206k | 36.81 |
| 2016-12-31 | $6.4M | 201k | 31.88 |
| 2016-09-30 | $8.0M | 222k | 36.24 |
| 2016-06-30 | $4.1M | 180k | 22.70 |